nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetylsalicylic acid—migraine—Prednisone—multiple sclerosis	0.152	0.341	CpDpCtD
Acetylsalicylic acid—osteoarthritis—Prednisone—multiple sclerosis	0.147	0.33	CpDpCtD
Acetylsalicylic acid—osteoarthritis—Methylprednisolone—multiple sclerosis	0.147	0.33	CpDpCtD
Acetylsalicylic acid—ALB—multiple sclerosis	0.111	1	CbGaD
Acetylsalicylic acid—PTGS2—Triamcinolone—multiple sclerosis	0.0308	0.144	CbGbCtD
Acetylsalicylic acid—PTGS2—Betamethasone—multiple sclerosis	0.0265	0.124	CbGbCtD
Acetylsalicylic acid—SLC22A7—Methotrexate—multiple sclerosis	0.0215	0.101	CbGbCtD
Acetylsalicylic acid—ALB—Prednisone—multiple sclerosis	0.0156	0.0728	CbGbCtD
Acetylsalicylic acid—PTGS2—Dexamethasone—multiple sclerosis	0.0154	0.072	CbGbCtD
Acetylsalicylic acid—ABCB1—Methylprednisolone—multiple sclerosis	0.0134	0.0628	CbGbCtD
Acetylsalicylic acid—CYP2C19—Prednisone—multiple sclerosis	0.0101	0.0472	CbGbCtD
Acetylsalicylic acid—ABCB1—Mitoxantrone—multiple sclerosis	0.00979	0.0458	CbGbCtD
Acetylsalicylic acid—SLC22A6—Methotrexate—multiple sclerosis	0.00916	0.0429	CbGbCtD
Acetylsalicylic acid—ABCB1—Betamethasone—multiple sclerosis	0.00873	0.0408	CbGbCtD
Acetylsalicylic acid—ABCB1—Prednisolone—multiple sclerosis	0.00861	0.0403	CbGbCtD
Acetylsalicylic acid—ABCB1—Prednisone—multiple sclerosis	0.00813	0.0381	CbGbCtD
Acetylsalicylic acid—ALB—Methotrexate—multiple sclerosis	0.0078	0.0365	CbGbCtD
Acetylsalicylic acid—CYP2C8—Dexamethasone—multiple sclerosis	0.0075	0.0351	CbGbCtD
Acetylsalicylic acid—CYP2C19—Dexamethasone—multiple sclerosis	0.00629	0.0294	CbGbCtD
Acetylsalicylic acid—CYP2C9—Dexamethasone—multiple sclerosis	0.00523	0.0245	CbGbCtD
Acetylsalicylic acid—ABCB1—Dexamethasone—multiple sclerosis	0.00508	0.0238	CbGbCtD
Acetylsalicylic acid—HSPA5—pineal body—multiple sclerosis	0.00437	0.0962	CbGeAlD
Acetylsalicylic acid—ABCB1—Methotrexate—multiple sclerosis	0.00408	0.0191	CbGbCtD
Acetylsalicylic acid—NFKBIA—nerve—multiple sclerosis	0.00324	0.0714	CbGeAlD
Acetylsalicylic acid—HSPA5—nerve—multiple sclerosis	0.00318	0.0699	CbGeAlD
Acetylsalicylic acid—TP53—brainstem—multiple sclerosis	0.00142	0.0311	CbGeAlD
Acetylsalicylic acid—NFKBIA—brainstem—multiple sclerosis	0.00139	0.0306	CbGeAlD
Acetylsalicylic acid—HSPA5—brainstem—multiple sclerosis	0.00136	0.03	CbGeAlD
Acetylsalicylic acid—NFKBIA—retina—multiple sclerosis	0.00134	0.0296	CbGeAlD
Acetylsalicylic acid—HSPA5—retina—multiple sclerosis	0.00132	0.0289	CbGeAlD
Acetylsalicylic acid—PTGS2—leg—multiple sclerosis	0.00117	0.0257	CbGeAlD
Acetylsalicylic acid—RPS6KA3—retina—multiple sclerosis	0.00112	0.0247	CbGeAlD
Acetylsalicylic acid—NFKBIA—medulla oblongata—multiple sclerosis	0.000971	0.0214	CbGeAlD
Acetylsalicylic acid—HSPA5—medulla oblongata—multiple sclerosis	0.000951	0.0209	CbGeAlD
Acetylsalicylic acid—NFKBIA—midbrain—multiple sclerosis	0.000887	0.0195	CbGeAlD
Acetylsalicylic acid—TP53—spinal cord—multiple sclerosis	0.00088	0.0194	CbGeAlD
Acetylsalicylic acid—HSPA5—midbrain—multiple sclerosis	0.000869	0.0191	CbGeAlD
Acetylsalicylic acid—NFKBIA—spinal cord—multiple sclerosis	0.000866	0.019	CbGeAlD
Acetylsalicylic acid—HSPA5—spinal cord—multiple sclerosis	0.000848	0.0187	CbGeAlD
Acetylsalicylic acid—RPS6KA3—medulla oblongata—multiple sclerosis	0.00081	0.0178	CbGeAlD
Acetylsalicylic acid—TP53—nervous system—multiple sclerosis	0.000741	0.0163	CbGeAlD
Acetylsalicylic acid—RPS6KA3—midbrain—multiple sclerosis	0.00074	0.0163	CbGeAlD
Acetylsalicylic acid—NFKBIA—nervous system—multiple sclerosis	0.000729	0.0161	CbGeAlD
Acetylsalicylic acid—RPS6KA3—spinal cord—multiple sclerosis	0.000722	0.0159	CbGeAlD
Acetylsalicylic acid—HSPA5—nervous system—multiple sclerosis	0.000714	0.0157	CbGeAlD
Acetylsalicylic acid—TP53—central nervous system—multiple sclerosis	0.000714	0.0157	CbGeAlD
Acetylsalicylic acid—NFKBIA—central nervous system—multiple sclerosis	0.000702	0.0155	CbGeAlD
Acetylsalicylic acid—TP53—cerebellum—multiple sclerosis	0.000698	0.0154	CbGeAlD
Acetylsalicylic acid—HSPA5—central nervous system—multiple sclerosis	0.000688	0.0151	CbGeAlD
Acetylsalicylic acid—NFKBIA—cerebellum—multiple sclerosis	0.000686	0.0151	CbGeAlD
Acetylsalicylic acid—HSPA5—cerebellum—multiple sclerosis	0.000672	0.0148	CbGeAlD
Acetylsalicylic acid—EDNRA—medulla oblongata—multiple sclerosis	0.000658	0.0145	CbGeAlD
Acetylsalicylic acid—RPS6KA3—nervous system—multiple sclerosis	0.000609	0.0134	CbGeAlD
Acetylsalicylic acid—EDNRA—midbrain—multiple sclerosis	0.000602	0.0132	CbGeAlD
Acetylsalicylic acid—RPS6KA3—central nervous system—multiple sclerosis	0.000586	0.0129	CbGeAlD
Acetylsalicylic acid—RPS6KA3—cerebellum—multiple sclerosis	0.000573	0.0126	CbGeAlD
Acetylsalicylic acid—TP53—brain—multiple sclerosis	0.000567	0.0125	CbGeAlD
Acetylsalicylic acid—NFKBIA—brain—multiple sclerosis	0.000558	0.0123	CbGeAlD
Acetylsalicylic acid—HSPA5—brain—multiple sclerosis	0.000546	0.012	CbGeAlD
Acetylsalicylic acid—RPS6KA3—brain—multiple sclerosis	0.000465	0.0102	CbGeAlD
Acetylsalicylic acid—IKBKB—nervous system—multiple sclerosis	0.000449	0.00989	CbGeAlD
Acetylsalicylic acid—IKBKB—central nervous system—multiple sclerosis	0.000432	0.00952	CbGeAlD
Acetylsalicylic acid—IKBKB—cerebellum—multiple sclerosis	0.000423	0.0093	CbGeAlD
Acetylsalicylic acid—EDNRA—brain—multiple sclerosis	0.000378	0.00832	CbGeAlD
Acetylsalicylic acid—IKBKB—brain—multiple sclerosis	0.000343	0.00756	CbGeAlD
Acetylsalicylic acid—TP53—Testosterone—Prednisolone—multiple sclerosis	0.00034	0.157	CbGdCrCtD
Acetylsalicylic acid—SLC22A7—brain—multiple sclerosis	0.000333	0.00733	CbGeAlD
Acetylsalicylic acid—SLC22A6—brain—multiple sclerosis	0.000322	0.00708	CbGeAlD
Acetylsalicylic acid—TP53—Danazol—Prednisone—multiple sclerosis	0.000283	0.131	CbGdCrCtD
Acetylsalicylic acid—Diabetes mellitus—Methylprednisolone—multiple sclerosis	0.000254	0.00411	CcSEcCtD
Acetylsalicylic acid—Haemoglobin—Azathioprine—multiple sclerosis	0.000252	0.00409	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Azathioprine—multiple sclerosis	0.000251	0.00406	CcSEcCtD
Acetylsalicylic acid—Anaemia—Cladribine—multiple sclerosis	0.000249	0.00402	CcSEcCtD
Acetylsalicylic acid—Vascular purpura—Triamcinolone—multiple sclerosis	0.000248	0.00401	CcSEcCtD
Acetylsalicylic acid—PTGS2—Fluocinonide—Methylprednisolone—multiple sclerosis	0.000245	0.113	CbGdCrCtD
Acetylsalicylic acid—PTGS2—Fluocinonide—Betamethasone—multiple sclerosis	0.000241	0.111	CbGdCrCtD
Acetylsalicylic acid—PTGS2—Fluocinonide—Dexamethasone—multiple sclerosis	0.000241	0.111	CbGdCrCtD
Acetylsalicylic acid—PTGS2—Fluocinonide—Triamcinolone—multiple sclerosis	0.000236	0.109	CbGdCrCtD
Acetylsalicylic acid—Diabetes mellitus—Dexamethasone—multiple sclerosis	0.000231	0.00374	CcSEcCtD
Acetylsalicylic acid—Diabetes mellitus—Betamethasone—multiple sclerosis	0.000231	0.00374	CcSEcCtD
Acetylsalicylic acid—Purpura—Triamcinolone—multiple sclerosis	0.00023	0.00372	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Cladribine—multiple sclerosis	0.000229	0.0037	CcSEcCtD
Acetylsalicylic acid—Chest pain—Cladribine—multiple sclerosis	0.000229	0.0037	CcSEcCtD
Acetylsalicylic acid—Drowsiness—Mitoxantrone—multiple sclerosis	0.000226	0.00366	CcSEcCtD
Acetylsalicylic acid—Confusional state—Cladribine—multiple sclerosis	0.000221	0.00358	CcSEcCtD
Acetylsalicylic acid—Sweating—Mitoxantrone—multiple sclerosis	0.000217	0.00351	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Cladribine—multiple sclerosis	0.000215	0.00348	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Cladribine—multiple sclerosis	0.000214	0.00347	CcSEcCtD
Acetylsalicylic acid—Ulcer—Methotrexate—multiple sclerosis	0.000213	0.00345	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Cladribine—multiple sclerosis	0.000212	0.00343	CcSEcCtD
Acetylsalicylic acid—Respiratory failure—Methotrexate—multiple sclerosis	0.000205	0.00332	CcSEcCtD
Acetylsalicylic acid—Haemoglobin—Mitoxantrone—multiple sclerosis	0.000204	0.0033	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Mitoxantrone—multiple sclerosis	0.000203	0.00329	CcSEcCtD
Acetylsalicylic acid—Anaemia—Azathioprine—multiple sclerosis	0.000202	0.00327	CcSEcCtD
Acetylsalicylic acid—Diabetes mellitus—Prednisone—multiple sclerosis	0.000201	0.00326	CcSEcCtD
Acetylsalicylic acid—ALB—brain—multiple sclerosis	0.0002	0.00441	CbGeAlD
Acetylsalicylic acid—Melaena—Methotrexate—multiple sclerosis	0.000197	0.00318	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Azathioprine—multiple sclerosis	0.000196	0.00317	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Cladribine—multiple sclerosis	0.000196	0.00317	CcSEcCtD
Acetylsalicylic acid—Vascular purpura—Prednisone—multiple sclerosis	0.000196	0.00317	CcSEcCtD
Acetylsalicylic acid—Somnolence—Cladribine—multiple sclerosis	0.000195	0.00316	CcSEcCtD
Acetylsalicylic acid—Influenza—Triamcinolone—multiple sclerosis	0.000191	0.0031	CcSEcCtD
Acetylsalicylic acid—Asthma—Triamcinolone—multiple sclerosis	0.000191	0.0031	CcSEcCtD
Acetylsalicylic acid—PTGS2—medulla oblongata—multiple sclerosis	0.00019	0.00418	CbGeAlD
Acetylsalicylic acid—Arthralgia—Azathioprine—multiple sclerosis	0.000186	0.00301	CcSEcCtD
Acetylsalicylic acid—Coma—Methotrexate—multiple sclerosis	0.000184	0.00298	CcSEcCtD
Acetylsalicylic acid—Hypokalaemia—Betamethasone—multiple sclerosis	0.000183	0.00296	CcSEcCtD
Acetylsalicylic acid—Hypokalaemia—Dexamethasone—multiple sclerosis	0.000183	0.00296	CcSEcCtD
Acetylsalicylic acid—Purpura—Prednisone—multiple sclerosis	0.000182	0.00294	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Cladribine—multiple sclerosis	0.000181	0.00293	CcSEcCtD
Acetylsalicylic acid—PTGS1—spinal cord—multiple sclerosis	0.000177	0.0039	CbGeAlD
Acetylsalicylic acid—Gastrointestinal haemorrhage—Prednisone—multiple sclerosis	0.000175	0.00283	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Azathioprine—multiple sclerosis	0.000175	0.00283	CcSEcCtD
Acetylsalicylic acid—Urticaria—Cladribine—multiple sclerosis	0.000174	0.00282	CcSEcCtD
Acetylsalicylic acid—PTGS2—midbrain—multiple sclerosis	0.000174	0.00382	CbGeAlD
Acetylsalicylic acid—PTGS2—spinal cord—multiple sclerosis	0.00017	0.00373	CbGeAlD
Acetylsalicylic acid—Diabetes mellitus—Methotrexate—multiple sclerosis	0.000168	0.00272	CcSEcCtD
Acetylsalicylic acid—Haemoglobin—Prednisolone—multiple sclerosis	0.000167	0.00271	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Prednisolone—multiple sclerosis	0.000167	0.0027	CcSEcCtD
Acetylsalicylic acid—Polyuria—Methotrexate—multiple sclerosis	0.000167	0.0027	CcSEcCtD
Acetylsalicylic acid—Anaemia—Mitoxantrone—multiple sclerosis	0.000163	0.00264	CcSEcCtD
Acetylsalicylic acid—Sweating—Methylprednisolone—multiple sclerosis	0.000163	0.00264	CcSEcCtD
Acetylsalicylic acid—ABCB1—retina—multiple sclerosis	0.000163	0.00358	CbGeAlD
Acetylsalicylic acid—Hypersensitivity—Cladribine—multiple sclerosis	0.000162	0.00262	CcSEcCtD
Acetylsalicylic acid—Hypokalaemia—Prednisone—multiple sclerosis	0.000159	0.00258	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Mitoxantrone—multiple sclerosis	0.000158	0.00256	CcSEcCtD
Acetylsalicylic acid—Pruritus—Cladribine—multiple sclerosis	0.000155	0.00251	CcSEcCtD
Acetylsalicylic acid—Haemoglobin—Triamcinolone—multiple sclerosis	0.000154	0.00249	CcSEcCtD
Acetylsalicylic acid—Haemoglobin—Methylprednisolone—multiple sclerosis	0.000154	0.00249	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Triamcinolone—multiple sclerosis	0.000153	0.00248	CcSEcCtD
Acetylsalicylic acid—Convulsion—Mitoxantrone—multiple sclerosis	0.000153	0.00248	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Methylprednisolone—multiple sclerosis	0.000153	0.00247	CcSEcCtD
Acetylsalicylic acid—Hypertension—Mitoxantrone—multiple sclerosis	0.000153	0.00247	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Mitoxantrone—multiple sclerosis	0.000151	0.00244	CcSEcCtD
Acetylsalicylic acid—Chest pain—Mitoxantrone—multiple sclerosis	0.000151	0.00244	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Cladribine—multiple sclerosis	0.00015	0.00243	CcSEcCtD
Acetylsalicylic acid—PTGS1—nervous system—multiple sclerosis	0.000149	0.00329	CbGeAlD
Acetylsalicylic acid—PTGS2—Fluticasone Propionate—Methylprednisolone—multiple sclerosis	0.000148	0.0682	CbGdCrCtD
Acetylsalicylic acid—Feeling abnormal—Azathioprine—multiple sclerosis	0.000147	0.00238	CcSEcCtD
Acetylsalicylic acid—PTGS2—Fluticasone Propionate—Dexamethasone—multiple sclerosis	0.000146	0.0671	CbGdCrCtD
Acetylsalicylic acid—PTGS2—Fluticasone Propionate—Betamethasone—multiple sclerosis	0.000146	0.0671	CbGdCrCtD
Acetylsalicylic acid—Confusional state—Mitoxantrone—multiple sclerosis	0.000145	0.00235	CcSEcCtD
Acetylsalicylic acid—Dizziness—Cladribine—multiple sclerosis	0.000145	0.00235	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Mitoxantrone—multiple sclerosis	0.000144	0.00233	CcSEcCtD
Acetylsalicylic acid—PTGS1—central nervous system—multiple sclerosis	0.000144	0.00317	CbGeAlD
Acetylsalicylic acid—PTGS2—nervous system—multiple sclerosis	0.000143	0.00314	CbGeAlD
Acetylsalicylic acid—PTGS2—Fluticasone Propionate—Triamcinolone—multiple sclerosis	0.000142	0.0656	CbGdCrCtD
Acetylsalicylic acid—Shock—Mitoxantrone—multiple sclerosis	0.000142	0.0023	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Mitoxantrone—multiple sclerosis	0.000141	0.00229	CcSEcCtD
Acetylsalicylic acid—CYP2C8—brain—multiple sclerosis	0.000141	0.0031	CbGeAlD
Acetylsalicylic acid—Tachycardia—Mitoxantrone—multiple sclerosis	0.000141	0.00228	CcSEcCtD
Acetylsalicylic acid—Haemoglobin—Betamethasone—multiple sclerosis	0.00014	0.00226	CcSEcCtD
Acetylsalicylic acid—Haemoglobin—Dexamethasone—multiple sclerosis	0.00014	0.00226	CcSEcCtD
Acetylsalicylic acid—Vomiting—Cladribine—multiple sclerosis	0.00014	0.00226	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Mitoxantrone—multiple sclerosis	0.000139	0.00226	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Betamethasone—multiple sclerosis	0.000139	0.00225	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Dexamethasone—multiple sclerosis	0.000139	0.00225	CcSEcCtD
Acetylsalicylic acid—Rash—Cladribine—multiple sclerosis	0.000138	0.00224	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Cladribine—multiple sclerosis	0.000138	0.00224	CcSEcCtD
Acetylsalicylic acid—PTGS2—central nervous system—multiple sclerosis	0.000138	0.00303	CbGeAlD
Acetylsalicylic acid—PTGS2—cerebellum—multiple sclerosis	0.000134	0.00296	CbGeAlD
Acetylsalicylic acid—Angioedema—Prednisolone—multiple sclerosis	0.000133	0.00214	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Azathioprine—multiple sclerosis	0.000131	0.00213	CcSEcCtD
Acetylsalicylic acid—Nausea—Cladribine—multiple sclerosis	0.00013	0.00211	CcSEcCtD
Acetylsalicylic acid—Vertigo—Prednisolone—multiple sclerosis	0.00013	0.00211	CcSEcCtD
Acetylsalicylic acid—Syncope—Prednisolone—multiple sclerosis	0.00013	0.0021	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Mitoxantrone—multiple sclerosis	0.000129	0.00208	CcSEcCtD
Acetylsalicylic acid—Somnolence—Mitoxantrone—multiple sclerosis	0.000128	0.00208	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Prednisolone—multiple sclerosis	0.000127	0.00206	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000127	0.00205	CcSEcCtD
Acetylsalicylic acid—Asthma—Methotrexate—multiple sclerosis	0.000126	0.00205	CcSEcCtD
Acetylsalicylic acid—Convulsion—Prednisolone—multiple sclerosis	0.000126	0.00203	CcSEcCtD
Acetylsalicylic acid—Hypertension—Prednisolone—multiple sclerosis	0.000125	0.00203	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Azathioprine—multiple sclerosis	0.000122	0.00198	CcSEcCtD
Acetylsalicylic acid—Angioedema—Triamcinolone—multiple sclerosis	0.000122	0.00197	CcSEcCtD
Acetylsalicylic acid—Haemoglobin—Prednisone—multiple sclerosis	0.000122	0.00197	CcSEcCtD
Acetylsalicylic acid—Angioedema—Methylprednisolone—multiple sclerosis	0.000122	0.00197	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Prednisone—multiple sclerosis	0.000121	0.00196	CcSEcCtD
Acetylsalicylic acid—Vertigo—Triamcinolone—multiple sclerosis	0.00012	0.00194	CcSEcCtD
Acetylsalicylic acid—Syncope—Triamcinolone—multiple sclerosis	0.00012	0.00194	CcSEcCtD
Acetylsalicylic acid—Vertigo—Methylprednisolone—multiple sclerosis	0.00012	0.00193	CcSEcCtD
Acetylsalicylic acid—Syncope—Methylprednisolone—multiple sclerosis	0.000119	0.00193	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000119	0.00192	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Prednisolone—multiple sclerosis	0.000118	0.00192	CcSEcCtD
Acetylsalicylic acid—Dizziness—Azathioprine—multiple sclerosis	0.000118	0.00191	CcSEcCtD
Acetylsalicylic acid—ABCB1—medulla oblongata—multiple sclerosis	0.000118	0.00259	CbGeAlD
Acetylsalicylic acid—Loss of consciousness—Triamcinolone—multiple sclerosis	0.000117	0.0019	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.000117	0.00189	CcSEcCtD
Acetylsalicylic acid—Shock—Prednisolone—multiple sclerosis	0.000116	0.00188	CcSEcCtD
Acetylsalicylic acid—Convulsion—Triamcinolone—multiple sclerosis	0.000116	0.00187	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Prednisolone—multiple sclerosis	0.000116	0.00187	CcSEcCtD
Acetylsalicylic acid—Convulsion—Methylprednisolone—multiple sclerosis	0.000115	0.00187	CcSEcCtD
Acetylsalicylic acid—Hypertension—Triamcinolone—multiple sclerosis	0.000115	0.00186	CcSEcCtD
Acetylsalicylic acid—Hypertension—Methylprednisolone—multiple sclerosis	0.000115	0.00186	CcSEcCtD
Acetylsalicylic acid—Urticaria—Mitoxantrone—multiple sclerosis	0.000115	0.00185	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000114	0.00185	CcSEcCtD
Acetylsalicylic acid—PTGS1—brain—multiple sclerosis	0.000114	0.00251	CbGeAlD
Acetylsalicylic acid—Vomiting—Azathioprine—multiple sclerosis	0.000113	0.00184	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Methylprednisolone—multiple sclerosis	0.000113	0.00183	CcSEcCtD
Acetylsalicylic acid—Drowsiness—Methotrexate—multiple sclerosis	0.000113	0.00182	CcSEcCtD
Acetylsalicylic acid—Rash—Azathioprine—multiple sclerosis	0.000113	0.00182	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Azathioprine—multiple sclerosis	0.000112	0.00182	CcSEcCtD
Acetylsalicylic acid—Flushing—Prednisone—multiple sclerosis	0.000112	0.00182	CcSEcCtD
Acetylsalicylic acid—Angioedema—Dexamethasone—multiple sclerosis	0.000111	0.00179	CcSEcCtD
Acetylsalicylic acid—Angioedema—Betamethasone—multiple sclerosis	0.000111	0.00179	CcSEcCtD
Acetylsalicylic acid—Confusional state—Methylprednisolone—multiple sclerosis	0.00011	0.00177	CcSEcCtD
Acetylsalicylic acid—PTGS2—brain—multiple sclerosis	0.000109	0.0024	CbGeAlD
Acetylsalicylic acid—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000109	0.00176	CcSEcCtD
Acetylsalicylic acid—Vertigo—Dexamethasone—multiple sclerosis	0.000109	0.00176	CcSEcCtD
Acetylsalicylic acid—Vertigo—Betamethasone—multiple sclerosis	0.000109	0.00176	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000109	0.00176	CcSEcCtD
Acetylsalicylic acid—Syncope—Dexamethasone—multiple sclerosis	0.000109	0.00176	CcSEcCtD
Acetylsalicylic acid—Syncope—Betamethasone—multiple sclerosis	0.000109	0.00176	CcSEcCtD
Acetylsalicylic acid—Sweating—Methotrexate—multiple sclerosis	0.000108	0.00175	CcSEcCtD
Acetylsalicylic acid—ABCB1—midbrain—multiple sclerosis	0.000107	0.00237	CbGeAlD
Acetylsalicylic acid—Shock—Triamcinolone—multiple sclerosis	0.000107	0.00173	CcSEcCtD
Acetylsalicylic acid—Shock—Methylprednisolone—multiple sclerosis	0.000107	0.00173	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000106	0.00172	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Betamethasone—multiple sclerosis	0.000106	0.00172	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000106	0.00172	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Triamcinolone—multiple sclerosis	0.000106	0.00172	CcSEcCtD
Acetylsalicylic acid—Nausea—Azathioprine—multiple sclerosis	0.000106	0.00172	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Methylprednisolone—multiple sclerosis	0.000106	0.00172	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000105	0.0017	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000105	0.0017	CcSEcCtD
Acetylsalicylic acid—ABCB1—spinal cord—multiple sclerosis	0.000105	0.00231	CbGeAlD
Acetylsalicylic acid—Convulsion—Betamethasone—multiple sclerosis	0.000105	0.0017	CcSEcCtD
Acetylsalicylic acid—Convulsion—Dexamethasone—multiple sclerosis	0.000105	0.0017	CcSEcCtD
Acetylsalicylic acid—Hypertension—Betamethasone—multiple sclerosis	0.000104	0.00169	CcSEcCtD
Acetylsalicylic acid—Hypertension—Dexamethasone—multiple sclerosis	0.000104	0.00169	CcSEcCtD
Acetylsalicylic acid—Haemoglobin—Methotrexate—multiple sclerosis	0.000102	0.00165	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Methotrexate—multiple sclerosis	0.000101	0.00164	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Betamethasone—multiple sclerosis	9.88e-05	0.0016	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Dexamethasone—multiple sclerosis	9.88e-05	0.0016	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Mitoxantrone—multiple sclerosis	9.87e-05	0.0016	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Prednisolone—multiple sclerosis	9.75e-05	0.00158	CcSEcCtD
Acetylsalicylic acid—Anaemia—Prednisone—multiple sclerosis	9.74e-05	0.00158	CcSEcCtD
Acetylsalicylic acid—Shock—Betamethasone—multiple sclerosis	9.72e-05	0.00157	CcSEcCtD
Acetylsalicylic acid—Shock—Dexamethasone—multiple sclerosis	9.72e-05	0.00157	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Triamcinolone—multiple sclerosis	9.7e-05	0.00157	CcSEcCtD
Acetylsalicylic acid—Agitation—Prednisone—multiple sclerosis	9.69e-05	0.00157	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Betamethasone—multiple sclerosis	9.67e-05	0.00156	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Dexamethasone—multiple sclerosis	9.67e-05	0.00156	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Dexamethasone—multiple sclerosis	9.64e-05	0.00156	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Betamethasone—multiple sclerosis	9.64e-05	0.00156	CcSEcCtD
Acetylsalicylic acid—Angioedema—Prednisone—multiple sclerosis	9.63e-05	0.00156	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Triamcinolone—multiple sclerosis	9.58e-05	0.00155	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Methylprednisolone—multiple sclerosis	9.56e-05	0.00155	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Dexamethasone—multiple sclerosis	9.55e-05	0.00154	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Betamethasone—multiple sclerosis	9.55e-05	0.00154	CcSEcCtD
Acetylsalicylic acid—Vertigo—Prednisone—multiple sclerosis	9.47e-05	0.00153	CcSEcCtD
Acetylsalicylic acid—Syncope—Prednisone—multiple sclerosis	9.45e-05	0.00153	CcSEcCtD
Acetylsalicylic acid—Tinnitus—Methotrexate—multiple sclerosis	9.43e-05	0.00153	CcSEcCtD
Acetylsalicylic acid—Urticaria—Prednisolone—multiple sclerosis	9.4e-05	0.00152	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Prednisone—multiple sclerosis	9.26e-05	0.0015	CcSEcCtD
Acetylsalicylic acid—Vomiting—Mitoxantrone—multiple sclerosis	9.17e-05	0.00148	CcSEcCtD
Acetylsalicylic acid—Convulsion—Prednisone—multiple sclerosis	9.13e-05	0.00148	CcSEcCtD
Acetylsalicylic acid—Hypertension—Prednisone—multiple sclerosis	9.1e-05	0.00147	CcSEcCtD
Acetylsalicylic acid—Rash—Mitoxantrone—multiple sclerosis	9.1e-05	0.00147	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Mitoxantrone—multiple sclerosis	9.09e-05	0.00147	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Prednisone—multiple sclerosis	8.97e-05	0.00145	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Triamcinolone—multiple sclerosis	8.97e-05	0.00145	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Methylprednisolone—multiple sclerosis	8.95e-05	0.00145	CcSEcCtD
Acetylsalicylic acid—ABCB1—nervous system—multiple sclerosis	8.84e-05	0.00194	CbGeAlD
Acetylsalicylic acid—Hypersensitivity—Prednisolone—multiple sclerosis	8.72e-05	0.00141	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Betamethasone—multiple sclerosis	8.69e-05	0.00141	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Dexamethasone—multiple sclerosis	8.69e-05	0.00141	CcSEcCtD
Acetylsalicylic acid—Urticaria—Triamcinolone—multiple sclerosis	8.65e-05	0.0014	CcSEcCtD
Acetylsalicylic acid—Urticaria—Methylprednisolone—multiple sclerosis	8.63e-05	0.0014	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Prednisone—multiple sclerosis	8.6e-05	0.00139	CcSEcCtD
Acetylsalicylic acid—Nausea—Mitoxantrone—multiple sclerosis	8.57e-05	0.00139	CcSEcCtD
Acetylsalicylic acid—ABCB1—central nervous system—multiple sclerosis	8.51e-05	0.00187	CbGeAlD
Acetylsalicylic acid—Shock—Prednisone—multiple sclerosis	8.46e-05	0.00137	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Prednisone—multiple sclerosis	8.4e-05	0.00136	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Prednisone—multiple sclerosis	8.32e-05	0.00135	CcSEcCtD
Acetylsalicylic acid—ABCB1—cerebellum—multiple sclerosis	8.31e-05	0.00183	CbGeAlD
Acetylsalicylic acid—Anaemia—Methotrexate—multiple sclerosis	8.14e-05	0.00132	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Dexamethasone—multiple sclerosis	8.14e-05	0.00132	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Betamethasone—multiple sclerosis	8.14e-05	0.00132	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Triamcinolone—multiple sclerosis	8.02e-05	0.0013	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Methylprednisolone—multiple sclerosis	8e-05	0.00129	CcSEcCtD
Acetylsalicylic acid—Vertigo—Methotrexate—multiple sclerosis	7.91e-05	0.00128	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Methotrexate—multiple sclerosis	7.88e-05	0.00128	CcSEcCtD
Acetylsalicylic acid—Urticaria—Dexamethasone—multiple sclerosis	7.85e-05	0.00127	CcSEcCtD
Acetylsalicylic acid—Urticaria—Betamethasone—multiple sclerosis	7.85e-05	0.00127	CcSEcCtD
Acetylsalicylic acid—Dizziness—Prednisolone—multiple sclerosis	7.83e-05	0.00127	CcSEcCtD
Acetylsalicylic acid—Pruritus—Triamcinolone—multiple sclerosis	7.7e-05	0.00125	CcSEcCtD
Acetylsalicylic acid—Pruritus—Methylprednisolone—multiple sclerosis	7.68e-05	0.00124	CcSEcCtD
Acetylsalicylic acid—Convulsion—Methotrexate—multiple sclerosis	7.63e-05	0.00123	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Prednisone—multiple sclerosis	7.57e-05	0.00123	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Methotrexate—multiple sclerosis	7.5e-05	0.00121	CcSEcCtD
Acetylsalicylic acid—Chest pain—Methotrexate—multiple sclerosis	7.5e-05	0.00121	CcSEcCtD
Acetylsalicylic acid—Rash—Prednisolone—multiple sclerosis	7.46e-05	0.00121	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Prednisolone—multiple sclerosis	7.46e-05	0.00121	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Methylprednisolone—multiple sclerosis	7.43e-05	0.0012	CcSEcCtD
Acetylsalicylic acid—Confusional state—Methotrexate—multiple sclerosis	7.25e-05	0.00117	CcSEcCtD
Acetylsalicylic acid—Dizziness—Triamcinolone—multiple sclerosis	7.2e-05	0.00116	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Methotrexate—multiple sclerosis	7.19e-05	0.00116	CcSEcCtD
Acetylsalicylic acid—Dizziness—Methylprednisolone—multiple sclerosis	7.18e-05	0.00116	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Prednisone—multiple sclerosis	7.09e-05	0.00115	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Methotrexate—multiple sclerosis	7.04e-05	0.00114	CcSEcCtD
Acetylsalicylic acid—Nausea—Prednisolone—multiple sclerosis	7.03e-05	0.00114	CcSEcCtD
Acetylsalicylic acid—Pruritus—Betamethasone—multiple sclerosis	6.99e-05	0.00113	CcSEcCtD
Acetylsalicylic acid—Pruritus—Dexamethasone—multiple sclerosis	6.99e-05	0.00113	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Methotrexate—multiple sclerosis	6.95e-05	0.00112	CcSEcCtD
Acetylsalicylic acid—Vomiting—Triamcinolone—multiple sclerosis	6.92e-05	0.00112	CcSEcCtD
Acetylsalicylic acid—Vomiting—Methylprednisolone—multiple sclerosis	6.91e-05	0.00112	CcSEcCtD
Acetylsalicylic acid—Rash—Triamcinolone—multiple sclerosis	6.86e-05	0.00111	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Triamcinolone—multiple sclerosis	6.86e-05	0.00111	CcSEcCtD
Acetylsalicylic acid—Rash—Methylprednisolone—multiple sclerosis	6.85e-05	0.00111	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Methylprednisolone—multiple sclerosis	6.84e-05	0.00111	CcSEcCtD
Acetylsalicylic acid—Urticaria—Prednisone—multiple sclerosis	6.83e-05	0.00111	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Betamethasone—multiple sclerosis	6.76e-05	0.00109	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Dexamethasone—multiple sclerosis	6.76e-05	0.00109	CcSEcCtD
Acetylsalicylic acid—ABCB1—brain—multiple sclerosis	6.75e-05	0.00149	CbGeAlD
Acetylsalicylic acid—Dizziness—Betamethasone—multiple sclerosis	6.53e-05	0.00106	CcSEcCtD
Acetylsalicylic acid—Dizziness—Dexamethasone—multiple sclerosis	6.53e-05	0.00106	CcSEcCtD
Acetylsalicylic acid—Nausea—Triamcinolone—multiple sclerosis	6.47e-05	0.00105	CcSEcCtD
Acetylsalicylic acid—Nausea—Methylprednisolone—multiple sclerosis	6.45e-05	0.00104	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Methotrexate—multiple sclerosis	6.41e-05	0.00104	CcSEcCtD
Acetylsalicylic acid—Somnolence—Methotrexate—multiple sclerosis	6.39e-05	0.00103	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Prednisone—multiple sclerosis	6.34e-05	0.00103	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Methotrexate—multiple sclerosis	6.33e-05	0.00102	CcSEcCtD
Acetylsalicylic acid—Vomiting—Dexamethasone—multiple sclerosis	6.28e-05	0.00102	CcSEcCtD
Acetylsalicylic acid—Vomiting—Betamethasone—multiple sclerosis	6.28e-05	0.00102	CcSEcCtD
Acetylsalicylic acid—Rash—Dexamethasone—multiple sclerosis	6.23e-05	0.00101	CcSEcCtD
Acetylsalicylic acid—Rash—Betamethasone—multiple sclerosis	6.23e-05	0.00101	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Betamethasone—multiple sclerosis	6.22e-05	0.00101	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Dexamethasone—multiple sclerosis	6.22e-05	0.00101	CcSEcCtD
Acetylsalicylic acid—Pruritus—Prednisone—multiple sclerosis	6.09e-05	0.000985	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Methotrexate—multiple sclerosis	5.92e-05	0.000958	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Prednisone—multiple sclerosis	5.89e-05	0.000952	CcSEcCtD
Acetylsalicylic acid—Nausea—Dexamethasone—multiple sclerosis	5.87e-05	0.000949	CcSEcCtD
Acetylsalicylic acid—Nausea—Betamethasone—multiple sclerosis	5.87e-05	0.000949	CcSEcCtD
Acetylsalicylic acid—Urticaria—Methotrexate—multiple sclerosis	5.71e-05	0.000924	CcSEcCtD
Acetylsalicylic acid—Dizziness—Prednisone—multiple sclerosis	5.69e-05	0.00092	CcSEcCtD
Acetylsalicylic acid—Vomiting—Prednisone—multiple sclerosis	5.47e-05	0.000885	CcSEcCtD
Acetylsalicylic acid—Rash—Prednisone—multiple sclerosis	5.42e-05	0.000877	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Prednisone—multiple sclerosis	5.42e-05	0.000877	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Methotrexate—multiple sclerosis	5.3e-05	0.000857	CcSEcCtD
Acetylsalicylic acid—Nausea—Prednisone—multiple sclerosis	5.11e-05	0.000827	CcSEcCtD
Acetylsalicylic acid—Pruritus—Methotrexate—multiple sclerosis	5.09e-05	0.000823	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Methotrexate—multiple sclerosis	4.92e-05	0.000796	CcSEcCtD
Acetylsalicylic acid—Dizziness—Methotrexate—multiple sclerosis	4.75e-05	0.000769	CcSEcCtD
Acetylsalicylic acid—Vomiting—Methotrexate—multiple sclerosis	4.57e-05	0.00074	CcSEcCtD
Acetylsalicylic acid—Rash—Methotrexate—multiple sclerosis	4.53e-05	0.000733	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Methotrexate—multiple sclerosis	4.53e-05	0.000733	CcSEcCtD
Acetylsalicylic acid—Nausea—Methotrexate—multiple sclerosis	4.27e-05	0.000691	CcSEcCtD
Acetylsalicylic acid—NFKBIA—Immune System—CD4—multiple sclerosis	8.13e-06	6.85e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—CD80—multiple sclerosis	8.13e-06	6.85e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—ICAM1—multiple sclerosis	8.11e-06	6.83e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—GPCR downstream signaling—IL2—multiple sclerosis	8.06e-06	6.79e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—TYK2—multiple sclerosis	8.04e-06	6.77e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	8.03e-06	6.77e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—CCL2—multiple sclerosis	7.99e-06	6.74e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	7.99e-06	6.73e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Selenium Micronutrient Network—IL6—multiple sclerosis	7.98e-06	6.73e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—CD80—multiple sclerosis	7.81e-06	6.58e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Spinal Cord Injury—IL6—multiple sclerosis	7.8e-06	6.58e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Cytokine Signaling in Immune system—MAPK1—multiple sclerosis	7.79e-06	6.56e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—SPP1—multiple sclerosis	7.69e-06	6.48e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—SPP1—multiple sclerosis	7.69e-06	6.48e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling by NGF—MAPK1—multiple sclerosis	7.66e-06	6.45e-05	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Immune System—IL6—multiple sclerosis	7.66e-06	6.45e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—RRM1—multiple sclerosis	7.65e-06	6.45e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Developmental Biology—IL6—multiple sclerosis	7.64e-06	6.44e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—APOE—multiple sclerosis	7.62e-06	6.42e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Innate Immune System—IL6—multiple sclerosis	7.55e-06	6.36e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—APOE—multiple sclerosis	7.53e-06	6.34e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—IFNG—multiple sclerosis	7.53e-06	6.34e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—GPC5—multiple sclerosis	7.52e-06	6.33e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—IL1B—multiple sclerosis	7.51e-06	6.33e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—CCR5—multiple sclerosis	7.48e-06	6.3e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—CCR5—multiple sclerosis	7.48e-06	6.3e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	7.48e-06	6.3e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—IL2—multiple sclerosis	7.48e-06	6.3e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—GPC5—multiple sclerosis	7.47e-06	6.3e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—IL2RA—multiple sclerosis	7.37e-06	6.21e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—IL2RA—multiple sclerosis	7.37e-06	6.21e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	7.34e-06	6.18e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	7.34e-06	6.18e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—IL2—multiple sclerosis	7.32e-06	6.17e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—IL2—multiple sclerosis	7.32e-06	6.17e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—CD4—multiple sclerosis	7.27e-06	6.12e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—TYK2—multiple sclerosis	7.26e-06	6.12e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—STAT3—multiple sclerosis	7.26e-06	6.12e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—VCAM1—multiple sclerosis	7.22e-06	6.09e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—HLA-DQA1—multiple sclerosis	7.2e-06	6.07e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—RPL5—multiple sclerosis	7.17e-06	6.04e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	7.17e-06	6.04e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—CYP24A1—multiple sclerosis	7.16e-06	6.03e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—CYP27B1—multiple sclerosis	7.16e-06	6.03e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	7.06e-06	5.95e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	7.05e-06	5.94e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	6.91e-06	5.82e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—CD80—multiple sclerosis	6.89e-06	5.8e-05	CbGpPWpGaD
Acetylsalicylic acid—SLC22A6—Transmembrane transport of small molecules—ALB—multiple sclerosis	6.88e-06	5.8e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—SLC11A1—multiple sclerosis	6.87e-06	5.79e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—TYK2—multiple sclerosis	6.86e-06	5.78e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—APOE—multiple sclerosis	6.81e-06	5.74e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—APOE—multiple sclerosis	6.81e-06	5.74e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—CD80—multiple sclerosis	6.81e-06	5.73e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Innate Immune System—IL6—multiple sclerosis	6.75e-06	5.69e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—MYC—multiple sclerosis	6.75e-06	5.68e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—HLA-DQB1—multiple sclerosis	6.74e-06	5.68e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—TGFB1—multiple sclerosis	6.73e-06	5.67e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—IL1B—multiple sclerosis	6.71e-06	5.66e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—GPC5—multiple sclerosis	6.71e-06	5.65e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	6.69e-06	5.64e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	6.69e-06	5.64e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—IL2—multiple sclerosis	6.69e-06	5.63e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—MAPK1—multiple sclerosis	6.6e-06	5.56e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	6.58e-06	5.54e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—GPC5—multiple sclerosis	6.55e-06	5.52e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—POMC—multiple sclerosis	6.54e-06	5.51e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	6.54e-06	5.51e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	6.5e-06	5.48e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—CD86—multiple sclerosis	6.49e-06	5.47e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—POMC—multiple sclerosis	6.47e-06	5.45e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	6.43e-06	5.42e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—CCL2—multiple sclerosis	6.4e-06	5.39e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CCL3—multiple sclerosis	6.39e-06	5.38e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—CD40LG—multiple sclerosis	6.36e-06	5.36e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—CCL2—multiple sclerosis	6.33e-06	5.33e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—STAT3—multiple sclerosis	6.29e-06	5.3e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—CD8A—multiple sclerosis	6.29e-06	5.3e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—RRM1—multiple sclerosis	6.23e-06	5.25e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—CD4—multiple sclerosis	6.21e-06	5.23e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—RRM1—multiple sclerosis	6.19e-06	5.22e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—CD80—multiple sclerosis	6.15e-06	5.19e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—CD80—multiple sclerosis	6.15e-06	5.19e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—PTGER4—multiple sclerosis	6.15e-06	5.18e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—GPC5—multiple sclerosis	6.12e-06	5.15e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—HLA-B—multiple sclerosis	6.05e-06	5.1e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—PGR—multiple sclerosis	6.05e-06	5.1e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—IL2—multiple sclerosis	6.04e-06	5.09e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Cytokine Signaling in Immune system—IL6—multiple sclerosis	5.98e-06	5.04e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—CD4—multiple sclerosis	5.96e-06	5.02e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	5.94e-06	5e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CXCR3—multiple sclerosis	5.94e-06	5e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling by NGF—IL6—multiple sclerosis	5.88e-06	4.96e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CD28—multiple sclerosis	5.88e-06	4.96e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	5.86e-06	4.94e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—POMC—multiple sclerosis	5.85e-06	4.93e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—POMC—multiple sclerosis	5.85e-06	4.93e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—TYK2—multiple sclerosis	5.81e-06	4.9e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CCR2—multiple sclerosis	5.77e-06	4.87e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—TYK2—multiple sclerosis	5.75e-06	4.84e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—MAPK1—multiple sclerosis	5.72e-06	4.82e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—CCL2—multiple sclerosis	5.72e-06	4.82e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—CCL2—multiple sclerosis	5.72e-06	4.82e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—IL2RA—multiple sclerosis	5.72e-06	4.82e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—MMP9—multiple sclerosis	5.72e-06	4.82e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—IL2RA—multiple sclerosis	5.67e-06	4.78e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—STAT3—multiple sclerosis	5.63e-06	4.74e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—HLA-A—multiple sclerosis	5.61e-06	4.73e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—MAPK1—multiple sclerosis	5.6e-06	4.72e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—MAPK1—multiple sclerosis	5.6e-06	4.72e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—RRM1—multiple sclerosis	5.56e-06	4.68e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—BCHE—multiple sclerosis	5.54e-06	4.67e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—CD28—multiple sclerosis	5.49e-06	4.62e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—RRM1—multiple sclerosis	5.43e-06	4.57e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CNR1—multiple sclerosis	5.33e-06	4.49e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—TYK2—multiple sclerosis	5.2e-06	4.38e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—TYK2—multiple sclerosis	5.2e-06	4.38e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—TLR4—multiple sclerosis	5.13e-06	4.32e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—HLA-DRB1—multiple sclerosis	5.12e-06	4.32e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—MAPK1—multiple sclerosis	5.12e-06	4.31e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	5.1e-06	4.3e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—STAT3—multiple sclerosis	5.08e-06	4.28e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	5.07e-06	4.27e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—IL6—multiple sclerosis	5.07e-06	4.27e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—RRM1—multiple sclerosis	5.07e-06	4.27e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	5.01e-06	4.22e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	4.99e-06	4.21e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	4.97e-06	4.19e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—ICAM1—multiple sclerosis	4.92e-06	4.14e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	4.9e-06	4.13e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—IL2—multiple sclerosis	4.84e-06	4.08e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	4.83e-06	4.07e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	4.8e-06	4.05e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CXCL10—multiple sclerosis	4.8e-06	4.04e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—IL2—multiple sclerosis	4.78e-06	4.03e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—CD80—multiple sclerosis	4.73e-06	3.99e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—MYC—multiple sclerosis	4.72e-06	3.98e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—TGFB1—multiple sclerosis	4.71e-06	3.97e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	4.66e-06	3.93e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	4.65e-06	3.92e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—MAPK1—multiple sclerosis	4.62e-06	3.89e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—MMP9—multiple sclerosis	4.58e-06	3.86e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—MMP9—multiple sclerosis	4.52e-06	3.81e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—IL6—multiple sclerosis	4.4e-06	3.7e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—BCHE—multiple sclerosis	4.4e-06	3.7e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—MAPK1—multiple sclerosis	4.37e-06	3.68e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—IL2—multiple sclerosis	4.32e-06	3.64e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—IL2—multiple sclerosis	4.32e-06	3.64e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	4.31e-06	3.63e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—IL6—multiple sclerosis	4.3e-06	3.62e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—IL6—multiple sclerosis	4.3e-06	3.62e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CD86—multiple sclerosis	4.2e-06	3.54e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	4.15e-06	3.5e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CCL5—multiple sclerosis	4.13e-06	3.48e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	4.13e-06	3.48e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—MMP9—multiple sclerosis	4.09e-06	3.45e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—MMP9—multiple sclerosis	4.09e-06	3.45e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—STAT3—multiple sclerosis	4.07e-06	3.43e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—STAT3—multiple sclerosis	4.02e-06	3.39e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—TYK2—multiple sclerosis	4e-06	3.37e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	3.93e-06	3.31e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—IL6—multiple sclerosis	3.93e-06	3.31e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—CD86—multiple sclerosis	3.91e-06	3.3e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—SPP1—multiple sclerosis	3.83e-06	3.22e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	3.78e-06	3.19e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—MYC—multiple sclerosis	3.78e-06	3.19e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—TGFB1—multiple sclerosis	3.77e-06	3.18e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—IFNG—multiple sclerosis	3.74e-06	3.15e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—MYC—multiple sclerosis	3.74e-06	3.15e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—TGFB1—multiple sclerosis	3.73e-06	3.14e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CCR5—multiple sclerosis	3.72e-06	3.14e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	3.71e-06	3.12e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—MAPK1—multiple sclerosis	3.7e-06	3.12e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—IL2RA—multiple sclerosis	3.67e-06	3.09e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—MAPK1—multiple sclerosis	3.66e-06	3.08e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—STAT3—multiple sclerosis	3.64e-06	3.07e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—STAT3—multiple sclerosis	3.64e-06	3.07e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—CD4—multiple sclerosis	3.61e-06	3.05e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—BCHE—multiple sclerosis	3.58e-06	3.01e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—BCHE—multiple sclerosis	3.56e-06	3e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—IL6—multiple sclerosis	3.55e-06	2.99e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—CCR5—multiple sclerosis	3.47e-06	2.93e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—APOE—multiple sclerosis	3.39e-06	2.85e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—HLA-A—multiple sclerosis	3.38e-06	2.85e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—MYC—multiple sclerosis	3.38e-06	2.85e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—MYC—multiple sclerosis	3.38e-06	2.85e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	3.38e-06	2.85e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	3.38e-06	2.85e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—TGFB1—multiple sclerosis	3.37e-06	2.84e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—TGFB1—multiple sclerosis	3.37e-06	2.84e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—IL6—multiple sclerosis	3.36e-06	2.83e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—IL2—multiple sclerosis	3.35e-06	2.82e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—IL1B—multiple sclerosis	3.34e-06	2.81e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—APOE—multiple sclerosis	3.33e-06	2.81e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—IL2—multiple sclerosis	3.33e-06	2.8e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—MAPK1—multiple sclerosis	3.31e-06	2.79e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—MAPK1—multiple sclerosis	3.31e-06	2.79e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—BCHE—multiple sclerosis	3.19e-06	2.69e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—APOE—multiple sclerosis	3.16e-06	2.66e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.14e-06	2.64e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—BCHE—multiple sclerosis	3.12e-06	2.63e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	3.08e-06	2.6e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CD80—multiple sclerosis	3.06e-06	2.58e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—BCHE—multiple sclerosis	2.91e-06	2.45e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—POMC—multiple sclerosis	2.91e-06	2.45e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—POMC—multiple sclerosis	2.86e-06	2.41e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—CD80—multiple sclerosis	2.86e-06	2.41e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CCL2—multiple sclerosis	2.85e-06	2.4e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—IL6—multiple sclerosis	2.84e-06	2.4e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—IL6—multiple sclerosis	2.81e-06	2.37e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—STAT3—multiple sclerosis	2.8e-06	2.36e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—APOE—multiple sclerosis	2.64e-06	2.23e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—TGFB1—multiple sclerosis	2.61e-06	2.2e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—ALB—multiple sclerosis	2.61e-06	2.2e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—TYK2—multiple sclerosis	2.58e-06	2.18e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—MAPK1—multiple sclerosis	2.56e-06	2.16e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—MAPK1—multiple sclerosis	2.54e-06	2.14e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—IL6—multiple sclerosis	2.54e-06	2.14e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—IL6—multiple sclerosis	2.54e-06	2.14e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—TYK2—multiple sclerosis	2.41e-06	2.03e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—POMC—multiple sclerosis	2.27e-06	1.91e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—CD4—multiple sclerosis	2.18e-06	1.84e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—APOE—multiple sclerosis	2.15e-06	1.81e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—IL2—multiple sclerosis	2.15e-06	1.81e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—APOE—multiple sclerosis	2.14e-06	1.8e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—ALB—multiple sclerosis	2.07e-06	1.75e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—MMP9—multiple sclerosis	2.03e-06	1.71e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—IL6—multiple sclerosis	1.95e-06	1.65e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—APOE—multiple sclerosis	1.92e-06	1.62e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—APOE—multiple sclerosis	1.87e-06	1.58e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—POMC—multiple sclerosis	1.85e-06	1.56e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—POMC—multiple sclerosis	1.84e-06	1.55e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—STAT3—multiple sclerosis	1.81e-06	1.52e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—APOE—multiple sclerosis	1.75e-06	1.48e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—STAT3—multiple sclerosis	1.69e-06	1.42e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—ALB—multiple sclerosis	1.69e-06	1.42e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—MYC—multiple sclerosis	1.68e-06	1.42e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—TGFB1—multiple sclerosis	1.68e-06	1.41e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—POMC—multiple sclerosis	1.65e-06	1.39e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—MAPK1—multiple sclerosis	1.64e-06	1.39e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—POMC—multiple sclerosis	1.61e-06	1.36e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—MYC—multiple sclerosis	1.57e-06	1.32e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—TGFB1—multiple sclerosis	1.56e-06	1.32e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—MAPK1—multiple sclerosis	1.53e-06	1.29e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—POMC—multiple sclerosis	1.5e-06	1.27e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—ALB—multiple sclerosis	1.5e-06	1.27e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—ALB—multiple sclerosis	1.47e-06	1.24e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—ALB—multiple sclerosis	1.37e-06	1.16e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—IL6—multiple sclerosis	1.26e-06	1.06e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—IL6—multiple sclerosis	1.18e-06	9.93e-06	CbGpPWpGaD
